IARC – International Agency for Research on Cancer / World Health Organization shared a post on LinkedIn:
” ‘Lung Cancer has the epidemiological fingerprint of a ‘screenable’ cancer type’
IARC’s Dr Hilary Robbins presented at the G7 Cancer Conference on Poor Prognosis Cancers, organized by the French National Cancer Institute (Institut national du cancer) and NCC Japan, in Paris, with IARC Director Dr Elisabete Weiderpass and other IARC scientists in attendance.”
More posts featuring IARC on OncoDaily.
